Form 4: IFF Executive Leticia Goncalves Lourenco Acquires Restricted Stock Units
SEC Form 4
Leticia Goncalves Lourenco, President of Health & Bioscience at International Flavors & Fragrances Inc. (IFF), acquired 21,955 Restricted Stock Units (RSUs) on April 1, 2025.
Summary
- On April 1, 2025, Leticia Goncalves Lourenco, President of Health & Bioscience at International Flavors & Fragrances Inc. (IFF), acquired 21,955 Restricted Stock Units (RSUs).
- The RSUs convert to Common Stock on a one-for-one basis.
- The RSUs vest in three equal tranches with respect to 21,955 shares of Common Stock on each of April 1, 2026, April 1, 2027 and April 1, 2028, subject to continued employment with IFF.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. It reflects a standard executive compensation practice, indicating confidence in the company's future, but it's not overwhelmingly positive as it's a routine filing.
Positives
- The acquisition of RSUs by a high-ranking executive signals confidence in the company's future performance.
Future Outlook
The vesting schedule of the RSUs (April 1, 2026, April 1, 2027 and April 1, 2028) suggests a long-term commitment from the executive to the company's success.
Industry Context
Executive compensation in the flavors and fragrances industry often includes stock-based awards to align management interests with shareholder value. This RSU grant is a typical component of executive pay.
Comparison to Industry Standards
- Comparing this RSU grant to similar grants at companies like Givaudan or Firmenich (privately held) would require access to their executive compensation disclosures.
- Generally, RSU grants are a common practice to incentivize and retain key executives in the industry.
- The vesting schedule is fairly standard, with three-year vesting being a typical arrangement.
Stakeholder Impact
- Shareholders may view this as a positive sign, indicating that the executive's interests are aligned with theirs.
- Employees may see this as a sign of stability and commitment from the leadership team.
Key Dates
| Date | Description |
|---|---|
| 04/01/2025 | Date of transaction: Acquisition of 21,955 Restricted Stock Units. |
| 04/01/2026 | First vesting date for one-third of the RSUs (7,318 shares). |
| 04/01/2027 | Second vesting date for one-third of the RSUs (7,318 shares). |
| 04/01/2028 | Final vesting date for one-third of the RSUs (7,319 shares). |
| 04/02/2025 | Date of Form 4 filing. |
Keywords
Restricted Stock Units, IFF, Leticia Goncalves Lourenco, Form 4, Insider Transaction, Health & Bioscience, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.